HighPoint Advisor Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22,250
| Closed | -$4 | – | 701 |
|
|
2024
Q4 | $4 | Hold |
22,250
| – | – | ﹤0.01% | 695 |
|
|
2024
Q3 | $60 | Buy |
+22,250
| New | +$60 | ﹤0.01% | 692 |
|
|
2024
Q2 | – | Sell |
-22,250
| Closed | – | – | 647 |
|
|
2024
Q1 | $0 | Hold |
22,250
| – | – | ﹤0.01% | 671 |
|
|
2023
Q4 | $0 | Buy |
+22,250
| New | – | ﹤0.01% | 652 |
|
|
2022
Q2 | $51K | Buy |
+20,035
| New | +$34.6K | 0.01% | 515 |
|
|
2021
Q3 | $156K | Sell |
20,435
-500
| -2% | -$4.24K | 0.02% | 525 |
|
|
2021
Q2 | $203K | Sell |
20,935
-3,900
| -16% | -$31.1K | 0.02% | 505 |
|
|
2021
Q1 | $187K | Buy |
24,835
+250
| +1% | +$2.64K | 0.02% | 465 |
|
|
2020
Q4 | $396K | Buy |
+24,585
| New | +$197K | 0.05% | 300 |
|